Patent · US Active

Protein-polymer-drug conjugates

US9770519B2 · kind B2 · utility

1Cited by
36References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2015
Grant dateSep 26, 2017
Priority date
Expiry dateAug 24, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08L2203/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A drug conjugate is provided herein. The conjugate comprises a protein based recognition-molecule (PBRM) and a polymeric carrier substituted with one or more -LD-D, the protein based recognition-molecule being connected to the polymeric carrier by LP. Each occurrence of D is independently a therapeutic agent having a molecular weight ≦5 kDa. LD and LP are linkers connecting the therapeutic agent and PBRM to the polymeric carrier respectively. Also disclosed are polymeric scaffolds useful for conjugating with a PBRM to form a polymer-drug-PBRM conjugate described herein, compositions comprising the conjugates, methods of their preparation, and methods of treating various disorders with the conjugates or their compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.